{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:36:15Z","timestamp":1759451775512,"version":"build-2065373602"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00120-025-02675-6","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T12:15:38Z","timestamp":1758370538000},"page":"1024-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nachsorge von Hodentumoren\u00a0\u2013 ein Update","Follow-up in patients with testicular germ cell tumors\u2014an update"],"prefix":"10.1007","volume":"64","author":[{"given":"Klaus-Peter","family":"Dieckmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Angerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bremmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Soave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"2675_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-5347(17)58338-X","volume":"117","author":"LH Einhorn","year":"1977","unstructured":"Einhorn\u00a0LH, Donohue\u00a0JP (1977) Improved chemotherapy in disseminated testicular cancer. J\u00a0Urol 117:65\u201369","journal-title":"J Urol"},{"key":"2675_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1464-410X.1978.tb06223.x","volume":"50","author":"PJ Boyd","year":"1978","unstructured":"Boyd\u00a0PJ, Husband\u00a0JE, Peckham\u00a0MJ, Hendry\u00a0WF (1978) CT scanning and the surgery of metastatic teratoma of the testis: a\u00a0preliminary report. Br J Urol 50:609\u2013611","journal-title":"Br J Urol"},{"key":"2675_CR3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0140-6736(76)90044-1","volume":"2","author":"ES Newlands","year":"1976","unstructured":"Newlands\u00a0ES, Dent\u00a0J, Kardana\u00a0A, Searle\u00a0F, Bagshawe\u00a0KD (1976) Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours. Lancet 2:744\u2013745","journal-title":"Lancet"},{"key":"2675_CR4","first-page":"1340","volume":"82","author":"L Weissbach","year":"1985","unstructured":"Weissbach\u00a0L, Boedefeld\u00a0EA, Seeber\u00a0S (1985) Hodentumoren: Fr\u00fchzeitige Diagnose und stadiengerechte Therapie sichern den Erfolg. Dtsch \u00c4rztebl 82:1340\u20131349","journal-title":"Dtsch \u00c4rztebl"},{"key":"2675_CR5","first-page":"33","volume":"27","author":"W H\u00f6ppner","year":"1987","unstructured":"H\u00f6ppner\u00a0W, Hartmann\u00a0M (1987) Besonderheiten in der Nachsorge maligner Hodentumoren. Urologe\u00a0B 27:33\u201337","journal-title":"Urologe B"},{"key":"2675_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1055\/s-2008-1068604","volume":"111","author":"C Clemm","year":"1986","unstructured":"Clemm\u00a0C, Berdel\u00a0WE, Hartenstein\u00a0R, Nisenbaum\u00a0J, Fink\u00a0U, Rastetter\u00a0J, Wilmanns\u00a0W (1986) M\u00fcnchener Nachsorge-Schema bei fortgeschrittenen nichtseminomat\u00f6sen Keimzelltumoren. Dtsch Med Wochenschr 111:1181\u20131185","journal-title":"Dtsch Med Wochenschr"},{"key":"2675_CR7","first-page":"843","volume":"120","author":"S Krege","year":"2023","unstructured":"Krege\u00a0S, Oing\u00a0C, Bokemeyer\u00a0C (2023) Testicular tumors: high likelihood of cure with interdisciplinary management. Dtsch \u00c4rztebl Int 120:843\u2013854","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"2675_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jama.2024.27122","volume":"333","author":"N Singla","year":"2025","unstructured":"Singla\u00a0N, Bagrodia\u00a0A, Baraban\u00a0E, Fankhauser\u00a0CD, Ged\u00a0YMA (2025) Testicular germ cell tumors: a\u00a0review. JAMA 333:793\u2013803","journal-title":"JAMA"},{"key":"2675_CR9","first-page":"326","volume":"35","author":"KH Sch\u00f6lermann","year":"1996","unstructured":"Sch\u00f6lermann\u00a0KH, Dettmann\u00a0R, Hartmann\u00a0M (1996) Die risikogesteuerte Hodentumornachsorge. Urologe\u00a0A 35:326\u2013330","journal-title":"Urologe A"},{"key":"2675_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s00120-011-2556-0","volume":"50","author":"M Hartmann","year":"2011","unstructured":"Hartmann\u00a0M, Krege\u00a0S, Souchon\u00a0R, De Santis\u00a0M, Gillessen\u00a0S, Cathomas\u00a0R (2011) Nachsorge von Patienten mit Hodentumoren. Interdisziplin\u00e4re evidenzbasierte Empfehlungen. Urologe\u00a0A 50:830\u2013835","journal-title":"Urologe A"},{"key":"2675_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.urolonc.2017.06.047","volume":"36","author":"F Zengerling","year":"2018","unstructured":"Zengerling\u00a0F, Kunath\u00a0F, Jensen\u00a0K, Ruf\u00a0C, Schmidt\u00a0S, Spek\u00a0A (2018) Prognostic factors for tumor recurrence in patients with clinical stage\u00a0I seminoma undergoing surveillance\u2014a systematic review. Urol Oncol 36:448\u2013458","journal-title":"Urol Oncol"},{"key":"2675_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.euo.2023.10.014","volume":"7","author":"JL Boormans","year":"2024","unstructured":"Boormans\u00a0JL, Sylvester\u00a0R, Anson-Cartwright\u00a0L, Glicksman\u00a0RM, Hamilton\u00a0RJ, Hahn\u00a0E, Daugaard\u00a0G, Lauritsen\u00a0J, Wagner\u00a0T, Avuzzi\u00a0B, Nicolai\u00a0N, del Muro\u00a0XG, Aparicio\u00a0J, Stalder\u00a0O, Rothermundt\u00a0C, Fischer\u00a0S, Laguna\u00a0MP (2024) Prognostic factor risk groups for clinical stage\u00a0I seminoma: an individual patient data analysis by the European association of urology testicular cancer guidelines panel and guidelines office. Eur Urol Oncol 7:537\u2013543","journal-title":"Eur Urol Oncol"},{"key":"2675_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/bju.14618","volume":"124","author":"JM Blok","year":"2019","unstructured":"Blok\u00a0JM, Pluim\u00a0I, Daugaard\u00a0G, Wagner\u00a0T, J\u00f3\u017awiak\u00a0K, Wilthagen\u00a0EA, Looijenga\u00a0LHJ, Meijer\u00a0RP, Bosch\u00a0JLHR, Horenblas\u00a0S (2019) Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage\u00a0I nonseminomatous germ cell tumour: a\u00a0systematic review and meta-analysis. BJU Int 124:424\u2013430","journal-title":"BJU Int"},{"key":"2675_CR14","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","volume":"66","author":"MS Mortensen","year":"2014","unstructured":"Mortensen\u00a0MS, Lauritsen\u00a0J, Gundgaard\u00a0MG, Agerb\u00e6k\u00a0M, Holm\u00a0NV, Christensen\u00a0IJ, von der Maase\u00a0H, Daugaard\u00a0G (2014) A\u00a0nationwide cohort study of stage\u00a0I seminoma patients followed on a\u00a0surveillance program. Eur Urol 66:1172\u20131178","journal-title":"Eur Urol"},{"key":"2675_CR15","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/cncr.30458","volume":"123","author":"MS Mortensen","year":"2016","unstructured":"Mortensen\u00a0MS, Bandak\u00a0M, Kier\u00a0MG, Lauritsen\u00a0J, Agerbaek\u00a0M, Holm\u00a0NV, von der Maase\u00a0H, Daugaard\u00a0G (2016) Surveillance versus adjuvant radiotherapy for patients with high-risk stage\u00a0I seminoma. Cancer 123:1212\u20131218","journal-title":"Cancer"},{"key":"2675_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/annonc\/mdw164","volume":"27","author":"T Tandstad","year":"2016","unstructured":"Tandstad\u00a0T, St\u00e5hl\u00a0O, Dahl\u00a0O, Haugnes\u00a0HS, H\u00e5kansson\u00a0U, Karlsdottir \u00c5, Kjellman\u00a0A, Langberg\u00a0CW, Laurell\u00a0A, Oldenburg\u00a0J, Solberg\u00a0A, S\u00f6derstr\u00f6m\u00a0K, Stierner\u00a0U, Cavallin-St\u00e5hl\u00a0E, Wahlqvist\u00a0R, Wall\u00a0N, Cohn-Cedermark\u00a0G (2016) Treatment of stage\u00a0I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy, a\u00a0report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Ann Oncol 27:1299\u20131304","journal-title":"Ann Oncol"},{"key":"2675_CR17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00432-016-2162-z","volume":"142","author":"KP Dieckmann","year":"2016","unstructured":"Dieckmann\u00a0KP, Dralle-Filiz\u00a0I, Matthies\u00a0C, Heinzelbecker\u00a0J, Bedke\u00a0J, Ellinger\u00a0J, Anheuser\u00a0P, Souchon\u00a0R, Pichlmeier\u00a0U, Group GTCS (2016) Testicular seminoma clinical stage\u00a01\u2014treatment outcome on a\u00a0routine care level. J\u00a0Cancer Res Clin Oncol 142:1599\u20131607","journal-title":"J Cancer Res Clin Oncol"},{"key":"2675_CR18","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1200\/JCO.18.01250","volume":"37","author":"RJ Hamilton","year":"2019","unstructured":"Hamilton\u00a0RJ, Nayan\u00a0M, Anson-Cartwright\u00a0L, Atenafu\u00a0EG, Bedard\u00a0PL, Hansen\u00a0A, Chung\u00a0P, Warde\u00a0P, Sweet\u00a0J, O\u2019Malley\u00a0M, Sturgeon\u00a0J, Jewett\u00a0MAS (2019) Treatment of relapse of clinical stage\u00a0I nonseminomatous germ cell tumors on surveillance. J\u00a0Clin Oncol 37:1919\u20131926","journal-title":"J Clin Oncol"},{"key":"2675_CR19","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","volume":"32","author":"G Daugaard","year":"2014","unstructured":"Daugaard\u00a0G, Gundgaard\u00a0MG, Mortensen\u00a0MS, Agerb\u00e6k\u00a0M, Holm\u00a0NV, R\u00f8rth\u00a0M, von der Maase\u00a0H, Christensen\u00a0IJ, Lauritsen\u00a0J (2014) Surveillance for stage\u00a0I nonseminoma testicular cancer: outcomes and long-term follow-up in a\u00a0population-based cohort. J\u00a0Clin Oncol 32:3817\u20133823","journal-title":"J Clin Oncol"},{"key":"2675_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","volume":"33","author":"C Kollmannsberger","year":"2015","unstructured":"Kollmannsberger\u00a0C, Tandstad\u00a0T, Bedard\u00a0PL, Cohn-Cedermark\u00a0G, Chung\u00a0PW, Jewett\u00a0MA, Powles\u00a0T, Warde\u00a0PR, Daneshmand\u00a0S, Protheroe\u00a0A, Tyldesley\u00a0S, Black\u00a0PC, Chi\u00a0K, So\u00a0AI, Moore\u00a0MJ, Nichols\u00a0CR (2015) Patterns of relapse in patients with clinical stage\u00a0I testicular cancer managed with active surveillance. J\u00a0Clin Oncol 33:51\u201357","journal-title":"J Clin Oncol"},{"key":"2675_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221086813","author":"KP Dieckmann","year":"2022","unstructured":"Dieckmann\u00a0KP, Pokrivcak\u00a0T, Geczi\u00a0L, Niehaus\u00a0D, Dralle-Filiz\u00a0I, Matthies\u00a0C, Dienes\u00a0T, Zsch\u00e4bitz\u00a0S, Paffenholz\u00a0P, Gschliesser\u00a0T, Pichler\u00a0R, Mego\u00a0M, Bader\u00a0P, Zengerling\u00a0F, Heinzelbecker\u00a0J, Krausewitz\u00a0P, Krege\u00a0S, Aurilio\u00a0G, Aksoy\u00a0C, Hentrich\u00a0M, Seidel\u00a0C, T\u00f6rzs\u00f6k\u00a0P, Nestler\u00a0T, Majewski\u00a0M, Hiester\u00a0A, Buchler\u00a0T, Vallet\u00a0S, Studentova\u00a0H, Sch\u00f6nburg\u00a0S, Nieders\u00fc\u00df-Beke\u00a0D, Ring\u00a0J, Trenti\u00a0E, Heidenreich\u00a0A, W\u00fclfing\u00a0C, Isbarn\u00a0H, Pichlmeier\u00a0U, Pichler\u00a0M (2022) Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage\u00a01: outcome, safety, and risk factors for relapse in a\u00a0population-based study. Ther Adv Med Oncol. https:\/\/doi.org\/10.1177\/17588359221086813","journal-title":"Ther Adv Med Oncol"},{"key":"2675_CR22","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1200\/JCO.2007.12.0899","volume":"26","author":"P Albers","year":"2008","unstructured":"Albers\u00a0P, Siener\u00a0R, Krege\u00a0S, Schmelz\u00a0HU, Dieckmann\u00a0KP, Heidenreich\u00a0A, Kwasny\u00a0P, Pechoel\u00a0M, Lehmann\u00a0J, Kliesch\u00a0S, K\u00f6hrmann\u00a0KU, Fimmers\u00a0R, Weissbach\u00a0L, Loy\u00a0V, Wittekind\u00a0C, Hartmann\u00a0M, Group GTCS (2008) Randomized phase\u00a0III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage\u00a0I nonseminomatous testicular germ cell tumors: aUO trial AH 01\/94 by the German testicular cancer study group. J\u00a0Clin Oncol 26:2966\u20132972","journal-title":"J Clin Oncol"},{"key":"2675_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1200\/JCO.2003.06.065","volume":"21","author":"J Classen","year":"2003","unstructured":"Classen\u00a0J, Schmidberger\u00a0H, Meisner\u00a0C, Souchon\u00a0R, Sautter-Bihl\u00a0ML, Sauer\u00a0R, Weinknecht\u00a0S, K\u00f6hrmann\u00a0KU, Bamberg\u00a0M (2003) Radiotherapy for stages IIA\/B testicular seminoma: final report of a\u00a0prospective multicenter clinical trial. J\u00a0Clin Oncol 21:1101\u20131106","journal-title":"J Clin Oncol"},{"key":"2675_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/annonc\/mdq466","volume":"22","author":"C Kollmannsberger","year":"2011","unstructured":"Kollmannsberger\u00a0C, Tyldesley\u00a0S, Moore\u00a0C, Chi\u00a0KN, Murray\u00a0N, Daneshmand\u00a0S, Black\u00a0P, Duncan\u00a0G, Hayes-Lattin\u00a0B, Nichols\u00a0C (2011) Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. Ann Oncol 22:808\u2013814","journal-title":"Ann Oncol"},{"key":"2675_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.euros.2024.1005.1006","volume":"65","author":"A Thor","year":"2024","unstructured":"Thor\u00a0A, Negaard\u00a0HFS, Grenabo Bergdahl\u00a0A, Alm\u00e5s\u00a0B, Melsen Larsen\u00a0S, Lundgren\u00a0PO, Gerdtsson\u00a0A, Halvorsen\u00a0D, Johannsdottir\u00a0B, Jansson\u00a0AK, Hellstr\u00f6m\u00a0M, Wahlqvist\u00a0R, Langberg\u00a0CW, Hedlund\u00a0A, Akre\u00a0O, Glimelius\u00a0I, St\u00e5hl\u00a0O, Haugnes\u00a0HS, Cohn-Cedermark\u00a0G, Kjellman\u00a0A, Tandstad\u00a0T (2024) Primary retroperitoneal lymph node dissection as treatment for low-volume metastatic seminoma in a\u00a0population-based cohort: the Swedish Norwegian testicular cancer group experience. Eur Urol Open Sci 65:13\u201319. https:\/\/doi.org\/10.1016\/j.euros.2024.1005.1006","journal-title":"Eur Urol Open Sci"},{"key":"2675_CR26","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1200\/JCO.22.01822","volume":"41","author":"I Tachibana","year":"2023","unstructured":"Tachibana\u00a0I, Alabd\u00a0A, Tong\u00a0Y, Piroozi\u00a0A, Mahmoud\u00a0M, Kern\u00a0SQ, Masterson\u00a0TA, Adra\u00a0N, Foster\u00a0RS, Hanna\u00a0NH, Einhorn\u00a0LH, Cary\u00a0C (2023) Primary retroperitoneal lymph node dissection for stage\u00a0II seminoma: is surgery the new path forward? J\u00a0Clin Oncol 41:3930\u20133938","journal-title":"J Clin Oncol"},{"key":"2675_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/JU.0000000000003697","volume":"211","author":"RS Matulewicz","year":"2023","unstructured":"Matulewicz\u00a0RS, Benfante\u00a0N, Funt\u00a0SA, Feldman\u00a0DR, Carver\u00a0B, Doudt\u00a0A, Knezevic\u00a0A, Sheinfeld\u00a0J (2023) Primary retroperitoneal lymph node dissection for seminoma metastatic to the retroperitoneum. J\u00a0Urol 211:80\u201389. https:\/\/doi.org\/10.1097\/JU.0000000000003697","journal-title":"J Urol"},{"key":"2675_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1159\/000020197","volume":"37","author":"L Weissbach","year":"2000","unstructured":"Weissbach\u00a0L, Bussar-Maatz\u00a0R, Flechtner\u00a0H, Pichlmeier\u00a0U, Hartmann\u00a0M, Keller\u00a0L (2000) RPLND or primary chemotherapy in clinical stage IIA\/B nonseminomatous germ cell tumors? Results of a\u00a0prospective multicenter trial including quality of life assessment. Eur Urol 37:582\u2013594","journal-title":"Eur Urol"},{"key":"2675_CR29","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1200\/JCO.2007.12.0808","volume":"25","author":"AJ Stephenson","year":"2007","unstructured":"Stephenson\u00a0AJ, Bosl\u00a0GJ, Motzer\u00a0RJ, Bajorin\u00a0DF, Stasi\u00a0JP, Sheinfeld\u00a0J (2007) Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J\u00a0Clin Oncol 25:5597\u20135602","journal-title":"J Clin Oncol"},{"key":"2675_CR30","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1200\/JCO.19.02712","volume":"38","author":"DJ McHugh","year":"2020","unstructured":"McHugh\u00a0DJ, Funt\u00a0SA, Silber\u00a0D, Knezevic\u00a0A, Patil\u00a0S, O\u2019Donnell\u00a0D, Reuter\u00a0VE, Sheinfeld\u00a0J, Carver\u00a0BS, Motzer\u00a0RJ, Bajorin\u00a0DF, Bosl\u00a0GJ, Feldman\u00a0DR (2020) Adjuvant chemotherapy with etoposide plus cisplatin for patients with pathologic stage\u00a0II nonseminomatous germ cell tumors. J\u00a0Clin Oncol 38:1332\u20131337","journal-title":"J Clin Oncol"},{"key":"2675_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/cncr.11574","volume":"98","author":"D Gholam","year":"2003","unstructured":"Gholam\u00a0D, Fizazi\u00a0K, Terrier-Lacombe\u00a0MJ, Jan\u00a0P, Culine\u00a0S, Theodore\u00a0C (2003) Advanced seminoma\u2014treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a\u00a0single-institution experience in 145 patients. Cancer 98:745\u2013752","journal-title":"Cancer"},{"key":"2675_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/sj.bjc.6602020","volume":"91","author":"C Bokemeyer","year":"2004","unstructured":"Bokemeyer\u00a0C, Kollmannsberger\u00a0C, Stenning\u00a0S, Hartmann\u00a0JT, Horwich\u00a0A, Clemm\u00a0C, Gerl\u00a0A, Meisner\u00a0C, Ruckerl\u00a0CP, Schmoll\u00a0HJ, Kanz\u00a0L, Oliver\u00a0T (2004) Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a\u00a0pooled analysis of two randomised trials. Br J Cancer 91:683\u2013687","journal-title":"Br J Cancer"},{"key":"2675_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.eururo.2012.08.014","volume":"62","author":"S Daneshmand","year":"2012","unstructured":"Daneshmand\u00a0S, Albers\u00a0P, Foss\u00e5\u00a0SD, Heidenreich\u00a0A, Kollmannsberger\u00a0C, Krege\u00a0S, Nichols\u00a0C, Oldenburg\u00a0J, Wood\u00a0L (2012) Contemporary management of postchemotherapy testis cancer. Eur Urol 62:867\u2013876","journal-title":"Eur Urol"},{"key":"2675_CR34","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1200\/JCO.2007.13.6283","volume":"25","author":"BS Carver","year":"2007","unstructured":"Carver\u00a0BS, Serio\u00a0AM, Bajorin\u00a0D, Motzer\u00a0RJ, Stasi\u00a0J, Bosl\u00a0GJ, Vickers\u00a0AJ, Sheinfeld\u00a0J (2007) Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. J\u00a0Clin Oncol 25:5603\u20135608","journal-title":"J Clin Oncol"},{"key":"2675_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1200\/OP.23.00191","volume":"19","author":"C Conduit","year":"2023","unstructured":"Conduit\u00a0C, Lewin\u00a0J, Weickhardt\u00a0A, Lynam\u00a0J, Wong\u00a0S, Grimison\u00a0P, Sengupta\u00a0S, Pranavan\u00a0G, Parnis\u00a0F, Bastick\u00a0P, Campbell\u00a0D, Hansen\u00a0AR, Leonard\u00a0M, McJannett\u00a0M, Stockler\u00a0MR, Gibbs\u00a0P, Toner\u00a0G, Davis\u00a0ID, Tran\u00a0B, Kuchel\u00a0A (2023) Patterns of relapse in Australian patients with clinical stage\u00a01 testicular cancer: utility of the Australian and new zealand urogenital and prostate cancer trials group surveillance recommendations. JCO Oncol Pract 19:973\u2013980","journal-title":"JCO Oncol Pract"},{"key":"2675_CR36","doi-asserted-by":"publisher","first-page":"102365","DOI":"10.1016\/j.clgc.2025.102365","volume":"23","author":"AE Smith","year":"2025","unstructured":"Smith\u00a0AE, Zielinski\u00a0R, Grimison\u00a0P, Honeyball\u00a0F (2025) Review of relapse detection methods in stage\u00a01 testicular germ cell tumors in patients after orchidectomy managed with active surveillance: is physical examination required? Clin Genitourin Cancer 23:102365","journal-title":"Clin Genitourin Cancer"},{"key":"2675_CR37","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMra072149","volume":"357","author":"DK Brenner","year":"2007","unstructured":"Brenner\u00a0DK, Hall\u00a0EJ (2007) Computed tomography\u2014an increasing source of radiation exposure. N\u00a0Engl J Med 357:2277\u20132284","journal-title":"N Engl J Med"},{"key":"2675_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.juro.2008.10.005","volume":"181","author":"TV Tarin","year":"2009","unstructured":"Tarin\u00a0TV, Sonn\u00a0G, Shinghal\u00a0R (2009) Estimating the risk of cancer associated with imaging related radiation during surveillance for stage\u00a0I testicular cancer using computerized tomography. J\u00a0Urol 181:627\u2013632 (discussion 632\u2013623)","journal-title":"J Urol"},{"key":"2675_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00330-014-3507-0","volume":"25","author":"CJ Sullivan","year":"2015","unstructured":"Sullivan\u00a0CJ, Murphy\u00a0KP, McLaughlin\u00a0PD, Twomey\u00a0M, O\u2019Regan\u00a0KN, Power\u00a0DG, Maher\u00a0MM, O\u2019Connor\u00a0OJ (2015) Radiation exposure from diagnostic imaging in young patients with testicular cancer. Eur Radiol 25:1005\u20131013","journal-title":"Eur Radiol"},{"key":"2675_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000511245","volume":"105","author":"S Kliesch","year":"2021","unstructured":"Kliesch\u00a0S, Schmidt\u00a0S, Wilborn\u00a0D, Aigner\u00a0C, Albrecht\u00a0W, Bedke\u00a0J, Beintker\u00a0M, Beyersdorff\u00a0D, Bokemeyer\u00a0C, Busch\u00a0J, Classen\u00a0J, de Wit\u00a0M, Dieckmann\u00a0KP, Diemer\u00a0T, Dieing\u00a0A, Gockel\u00a0M, G\u00f6ckel-Beining\u00a0B, Hakenberg\u00a0OW, Heidenreich\u00a0A, Heinzelbecker\u00a0J, Herkommer\u00a0K, Hermanns\u00a0T, Kaufmann\u00a0S, Kornmann\u00a0M, Kotzerke\u00a0J, Krege\u00a0S, Kristiansen\u00a0G, Lorch\u00a0A, M\u00fcller\u00a0AC, Oechsle\u00a0K, Ohloff\u00a0T, Oing\u00a0C, Otto\u00a0U, Pfister\u00a0D, Pichler\u00a0R, Recken\u00a0H, Rick\u00a0O, Rudolph\u00a0Y, Ruf\u00a0C, Schirren\u00a0J, Schmelz\u00a0H, Schmidberger\u00a0H, Schrader\u00a0M, Schweyer\u00a0S, Seeling\u00a0S, Souchon\u00a0R, Winter\u00a0C, Wittekind\u00a0C, Zengerling\u00a0F, Zermann\u00a0DH, Zillmann\u00a0R, Albers\u00a0P (2021) Management of germ cell tumours of the testes in adult patients: German clinical practice guideline, PART II\u2014recommendations for the treatment of advanced, recurrent, and refractory disease and extragonadal and sex cord\/stromal tumours and for the management of follow-up, toxicity, quality of life, palliative care, and supportive therapy. Urol Int 105:181\u2013191","journal-title":"Urol Int"},{"key":"2675_CR41","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/0284186X.2020.1725243","volume":"59","author":"M Laukka","year":"2020","unstructured":"Laukka\u00a0M, Mannisto\u00a0S, Beule\u00a0A, Kouri\u00a0M, Blomqvist\u00a0C (2020) Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a\u00a0prospective trial. Acta Oncol 59:660\u2013665","journal-title":"Acta Oncol"},{"key":"2675_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/life12020212","volume":"12","author":"V Pasoglou","year":"2022","unstructured":"Pasoglou\u00a0V, Van Nieuwenhove\u00a0S, Van Damme\u00a0J, Michoux\u00a0N, Van Maanen\u00a0A, Annet\u00a0L, Machiels\u00a0JP, Tombal\u00a0B, Lecouvet\u00a0FE (2022) Whole body MRI in the detection of lymph node metastases in patients with testicular germ cell cancer. Life 12:212","journal-title":"Life"},{"key":"2675_CR43","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.21873\/anticanres.13427","volume":"39","author":"E Rud","year":"2019","unstructured":"Rud\u00a0E, Langberg\u00a0CW, Baco\u00a0E, Lauritzen\u00a0P, Sandb\u00e6k\u00a0G (2019) MRI in the follow-up of testicular cancer: less is more. Anticancer Res 39:2963\u20132968","journal-title":"Anticancer Res"},{"key":"2675_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.euros.2022.08.014","volume":"44","author":"E Kaufmann","year":"2022","unstructured":"Kaufmann\u00a0E, Antonelli\u00a0L, Albers\u00a0P, Cary\u00a0C, Gillessen Sommer\u00a0S, Heidenreich\u00a0A, Oing\u00a0C, Oldenburg\u00a0J, Pierorazio\u00a0PM, Stephenson\u00a0AJ, Fankhauser\u00a0CD (2022) Oncological follow-up strategies for testicular germ cell tumours: a\u00a0narrative review. Eur Urol Open Sci 44:142\u2013149","journal-title":"Eur Urol Open Sci"},{"key":"2675_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","volume":"84","author":"A Patrikidou","year":"2023","unstructured":"Patrikidou\u00a0A, Cazzaniga\u00a0W, Berney\u00a0D, Boormans\u00a0J, de Angst\u00a0I, Di Nardo\u00a0D, Fankhauser\u00a0C, Fischer\u00a0S, Gravina\u00a0C, Gremmels\u00a0H, Heidenreich\u00a0A, Janisch\u00a0F, Le\u00e3o\u00a0R, Nicolai\u00a0N, Oing\u00a0C, Oldenburg\u00a0J, Shepherd\u00a0R, Tandstad\u00a0T, Nicol\u00a0D (2023) European association of urology guidelines on testicular cancer: 2023 update. Eur Urol 84:289\u2013301","journal-title":"Eur Urol"},{"key":"2675_CR46","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1200\/JCO.21.01199","volume":"40","author":"JK Joffe","year":"2022","unstructured":"Joffe\u00a0JK, Cafferty\u00a0FH, Murphy\u00a0L, Rustin\u00a0GJS, Sohaib\u00a0SA, Gabe\u00a0R, Stenning\u00a0SP, James\u00a0E, Noor\u00a0D, Wade\u00a0S, Schiavone\u00a0F, Swift\u00a0S, Dunwoodie\u00a0E, Hall\u00a0M, Sharma\u00a0A, Braybrooke\u00a0J, Shamash\u00a0J, Logue\u00a0J, Taylor\u00a0HH, Hennig\u00a0I, White\u00a0J, Rudman\u00a0S, Worlding\u00a0J, Bloomfield\u00a0D, Faust\u00a0G, Glen\u00a0H, Jones\u00a0R, Seckl\u00a0M, MacDonald\u00a0G, Sreenivasan\u00a0T, Kumar\u00a0S, Protheroe\u00a0A, Venkitaraman\u00a0R, Mazhar\u00a0D, Coyle\u00a0V, Highley\u00a0M, Geldart\u00a0T, Laing\u00a0R, Kaplan\u00a0RS, Huddart\u00a0RA, Investigators TTMGa (2022) Imaging modality and frequency in surveillance of stage\u00a0I Seminoma testicular cancer: results from a\u00a0randomized, phase\u00a0III, noninferiority trial (TRISST). J\u00a0Clin Oncol 40:2468\u20132478","journal-title":"J Clin Oncol"},{"key":"2675_CR47","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1080\/0284186X.2020.1794035","volume":"59","author":"SKA Larsen","year":"2020","unstructured":"Larsen\u00a0SKA, Agerb\u00e6k\u00a0M, Jurik\u00a0AG, Pedersen\u00a0EM (2020) Ten years of experience with MRI follow-up of testicular cancer stage\u00a0I: a\u00a0retrospective study and an MRI protocol with DWI. Acta Oncol 59:1374\u20131381","journal-title":"Acta Oncol"},{"key":"2675_CR48","first-page":"7","volume-title":"Hodentumoren \u2013 Testis Cancer Charit\u00e9 Symposium","author":"M Hartmann","year":"1995","unstructured":"Hartmann\u00a0M, B\u00fcttner\u00a0H, Dettmann\u00a0R, Pottek\u00a0T (1995) Atypische Metastasierungen von Keimzelltumoren. In: Schnorr\u00a0D, Loening\u00a0SA, Weissbach\u00a0L (Hrsg) Hodentumoren \u2013 Testis Cancer Charit\u00e9 Symposium. Blackwell Wissenschafts-Verlag, Berlin, S\u00a07\u201326"},{"key":"2675_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1440-1673.1993.tb00012.x","volume":"37","author":"MJ Stevens","year":"1993","unstructured":"Stevens\u00a0MJ (1993) Skip metastases from testicular seminoma. Australas Radiol 37:67\u201368. https:\/\/doi.org\/10.1111\/j.1440-1673.1993.tb00012.x","journal-title":"Australas Radiol"},{"key":"2675_CR50","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ejca.2017.07.005","volume":"84","author":"H De La Pena","year":"2017","unstructured":"De La Pena\u00a0H et\u00a0al (2017) No longer any role for routine follow-up chest x\u2011rays in men with stage\u00a0I germ cell cancer. Eur J Cancer 84:354\u2013359","journal-title":"Eur J Cancer"},{"key":"2675_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.eururo.2009.06.029","volume":"57","author":"S Tolan","year":"2010","unstructured":"Tolan\u00a0S, Vesprini\u00a0D, Jewett\u00a0MA, Warde\u00a0PR, O\u2019Malley\u00a0M, Panzarella\u00a0T, Sturgeon\u00a0JF, Moore\u00a0M, Tew-George\u00a0B, Gospodarowicz\u00a0MK, Chung\u00a0PW (2010) No role for routine chest radiography in stage\u00a0I seminoma surveillance. Eur Urol 57:474\u2013479","journal-title":"Eur Urol"},{"key":"2675_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0009-9260(99)91152-2","volume":"54","author":"PM White","year":"1999","unstructured":"White\u00a0PM, Adamson\u00a0DJA, Howard\u00a0GC, Wright\u00a0AR (1999) Imaging of the thorax in the management of germ cell testicular tumours. Clin Radiol 54:207\u2013211","journal-title":"Clin Radiol"},{"key":"2675_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5030349","author":"KP Dieckmann","year":"2019","unstructured":"Dieckmann\u00a0KP, Simonsen-Richter\u00a0H, Kulejewski\u00a0M, Anheuser\u00a0P, Zecha\u00a0H, Isbarn\u00a0H, Pichlmeier\u00a0U (2019) Serum tumour markers in testicular germ cell tumours: frequencies of elevated levels and extents of marker elevation are significantly associated with clinical parameters and with response to treatment. Biomed Res Int. https:\/\/doi.org\/10.1155\/2019\/5030349","journal-title":"Biomed Res Int"},{"key":"2675_CR54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1055\/a-2422-0354","volume":"55","author":"J Schoch","year":"2024","unstructured":"Schoch\u00a0J, Schmelz\u00a0H, Dieckmann\u00a0KP, Nestler\u00a0T (2024) Neue Tumormarker bei Hodentumoren \u2013 im hier und jetzt und in der Zukunft. Aktuelle Urol 55:520\u2013527","journal-title":"Aktuelle Urol"},{"key":"2675_CR55","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/JU.0000000000002931","volume":"208","author":"A Bobrowski","year":"2022","unstructured":"Bobrowski\u00a0A, Anson-Cartwright\u00a0L, Kuhathaas\u00a0K, Jiang\u00a0DM, Chung\u00a0P, Bedard\u00a0P, Warde\u00a0P, O\u2019Malley\u00a0M, Sweet\u00a0J, Hamilton\u00a0RJ (2022) Role of lactate dehydrogenase (LDH) in identifying relapse for patients with stage\u00a0I testicular cancer on surveillance. J\u00a0Urol 208:1250\u20131258","journal-title":"J Urol"},{"key":"2675_CR56","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1097\/JU.0000000000001685","volume":"205","author":"NH Chakiryan","year":"2021","unstructured":"Chakiryan\u00a0NH, Dahmen\u00a0A, Cucchiara\u00a0V, Briganti\u00a0A, Montorsi\u00a0F, Salonia\u00a0A, Spiess\u00a0PE, Necchi\u00a0A (2021) Reliability of serum tumor marker measurement to diagnose recurrence in patients with clinical stage\u00a0I nonseminomatous germ cell tumors undergoing active surveillance: a\u00a0systematic review. J\u00a0Urol 205:1569\u20131576","journal-title":"J Urol"},{"key":"2675_CR57","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1200\/JCO.18.01480","volume":"37","author":"KP Dieckmann","year":"2019","unstructured":"Dieckmann\u00a0KP, Radtke\u00a0A, Geczi\u00a0L, Matthies\u00a0C, Anheuser\u00a0P, Eckardt\u00a0U, Sommer\u00a0J, Zengerling\u00a0F, Trenti\u00a0E, Pichler\u00a0R, Belz\u00a0H, Zastrow\u00a0S, Winter\u00a0A, Melchior\u00a0S, Hammel\u00a0J, Kranz\u00a0J, Bolten\u00a0M, Krege\u00a0S, Haben\u00a0B, Loidl\u00a0W, Ruf\u00a0CG, Heinzelbecker\u00a0J, Heidenreich\u00a0A, Cremers\u00a0JF, Oing\u00a0C, Hermanns\u00a0T, Fankhauser\u00a0CD, Gillessen\u00a0S, Reichegger\u00a0H, Cathomas\u00a0R, Pichler\u00a0M, Hentrich\u00a0M, Eredics\u00a0K, Lorch\u00a0A, W\u00fclfing\u00a0C, Peine\u00a0S, Wosniok\u00a0W, Bokemeyer\u00a0C, Belge\u00a0G (2019) Serum levels of microRNA-371a-3p (M371 test) as a\u00a0new biomarker of testicular germ cell-tumors: results of a\u00a0prospective multicentric study. J\u00a0Clin Oncol 37:1412\u20131423","journal-title":"J Clin Oncol"},{"key":"2675_CR58","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1078-0432.CCR-23-0730","volume":"30","author":"G Belge","year":"2024","unstructured":"Belge\u00a0G, Dumlupinar\u00a0C, Nestler\u00a0T, Klemke\u00a0M, T\u00f6rzs\u00f6k\u00a0P, Trenti\u00a0E, Pichler\u00a0R, Loidl\u00a0W, Che\u00a0Y, Hiester\u00a0A, Matthies\u00a0C, Pichler\u00a0M, Paffenholz\u00a0P, Kluth\u00a0L, Wenzel\u00a0M, Sommer\u00a0J, Heinzelbecker\u00a0J, Schriefer\u00a0P, Winter\u00a0A, Zengerling\u00a0F, Kramer\u00a0MW, Lengert\u00a0M, Frey\u00a0J, Heidenreich\u00a0A, W\u00fclfing\u00a0C, Radtke\u00a0A, Dieckmann\u00a0KP (2024) Detection of recurrence through microRNA-371a-3p serum levels in a\u00a0follow-up of stage\u00a0I testicular germ cell tumors in the DRKS-00019223 study. Clin Cancer Res 30:404\u2013412","journal-title":"Clin Cancer Res"},{"key":"2675_CR59","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41416-021-01643-z","volume":"126","author":"CD Fankhauser","year":"2022","unstructured":"Fankhauser\u00a0CD, Christiansen\u00a0AJ, Rothermundt\u00a0C, Cathomas\u00a0R, Wettstein\u00a0MS, Grossmann\u00a0NC, Grogg\u00a0JB, Templeton\u00a0AJ, Hirschi-Blickenstorfer\u00a0A, Lorch\u00a0A, Gillessen\u00a0S, Moch\u00a0H, Beyer\u00a0J, Hermanns\u00a0T (2022) Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage\u00a0I testicular germ cell tumours. Br J Cancer 126:1140\u20131144","journal-title":"Br J Cancer"},{"key":"2675_CR60","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euo.2020.11.004","volume":"4","author":"J Lobo","year":"2021","unstructured":"Lobo\u00a0J, Le\u00e3o\u00a0R, Gillis\u00a0AJM, van den Berg\u00a0A, Anson-Cartwright\u00a0L, Atenafu\u00a0EG, Kuhathaas\u00a0K, Chung\u00a0P, Hansen\u00a0A, Bedard\u00a0PL, Jewett\u00a0MAS, Warde\u00a0P, O\u2019Malley\u00a0M, Sweet\u00a0J, Looijenga\u00a0LHJ, Hamilton\u00a0RJ (2021) Utility of serum miR-371a-3p in predicting relapse on surveillance in patients with clinical stage\u00a0I testicular germ cell cancer. Eur Urol Oncol 4:483\u2013491","journal-title":"Eur Urol Oncol"},{"key":"2675_CR61","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1016\/j.clgc.2019.03.015","volume":"17","author":"D Charytonowicz","year":"2019","unstructured":"Charytonowicz\u00a0D, Aubrey\u00a0H, Bell\u00a0C, Ferret\u00a0M, Tsui\u00a0K, Atfield\u00a0R, Coleman\u00a0N, Murray\u00a0MJ, Wilson\u00a0ECF (2019) A\u00a0cost analysis of non-invasive blood-based microRNA testing versus CT scans for follow-up in patients with testicular germ cell tumors. Clin Genitourin Cancer 17:e733\u2013e744","journal-title":"Clin Genitourin Cancer"},{"key":"2675_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00120-010-2414-5","volume":"50","author":"S Krege","year":"2011","unstructured":"Krege\u00a0S, Albers\u00a0P, Heidenreich\u00a0A (2011) Markersysteme beim Hodentumor. Urologe\u00a0A 50:313\u2013321","journal-title":"Urologe A"},{"key":"2675_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000478706","volume":"99","author":"KP Dieckmann","year":"2017","unstructured":"Dieckmann\u00a0KP, Anheuser\u00a0P, Simonsen\u00a0H, H\u00f6flmayer\u00a0D (2017) Pure testicular seminoma with non-pathologic elevation of alpha fetoprotein: a\u00a0case series. Urol Int 99:353\u2013357","journal-title":"Urol Int"},{"key":"2675_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.euros.2024.1008.1008","volume":"68","author":"S Fischer","year":"2024","unstructured":"Fischer\u00a0S, Gillessen\u00a0S, Stalder\u00a0O, Terbuch\u00a0A, Cathomas\u00a0R, Schmid\u00a0FA, Zihler\u00a0D, M\u00fcller\u00a0B, Fankhauser\u00a0CD, Hirschi-Blickenstorfer\u00a0A, Kluth\u00a0LA, Seifert\u00a0B, Templeton\u00a0AJ, Mingrone\u00a0W, Ufe\u00a0MP, Fischer\u00a0N, Beyer\u00a0J, Woelky\u00a0R, Omlin\u00a0A, Vogl\u00a0U, Hoppe\u00a0K, Kamradt\u00a0J, Rothschild\u00a0SI, Rothermundt\u00a0C (2024) First indicator of relapse in testicular cancer and implications for follow-up: analysis of the Swiss Austrian German testicular cancer cohort study (SAG TCCS). Eur Urol Open Sci 68:68\u201374. https:\/\/doi.org\/10.1016\/j.euros.2024.1008.1008","journal-title":"Eur Urol Open Sci"},{"key":"2675_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.eururo.2006.05.051","volume":"51","author":"KP Dieckmann","year":"2007","unstructured":"Dieckmann\u00a0KP, Kulejewski\u00a0M, Pichlmeier\u00a0U, Loy\u00a0V (2007) Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a\u00a0single random biopsy. Eur Urol 51:175\u2013185","journal-title":"Eur Urol"},{"key":"2675_CR66","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1055\/s-0041-103446","volume":"47","author":"C Breunig","year":"2016","unstructured":"Breunig\u00a0C, Zengerling\u00a0F, Schn\u00f6ller\u00a0T, Schrader\u00a0M, Jentzmik\u00a0F (2016) Aktuelle Therapie organbegrenzter Hodentumoren. Aktuelle Urol 47:136\u2013140","journal-title":"Aktuelle Urol"},{"key":"2675_CR67","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/bju.16111","volume":"132","author":"J Chavarriaga","year":"2023","unstructured":"Chavarriaga\u00a0J, Bobrowski\u00a0A, Hamilton\u00a0RJ (2023) Guideline of guidelines: follow-up after orchidectomy for clinical stage\u00a01 testicular cancer. BJU Int 132:485\u2013495","journal-title":"BJU Int"},{"key":"2675_CR68","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","volume":"33","author":"J Oldenburg","year":"2022","unstructured":"Oldenburg\u00a0J, Berney\u00a0DM, Bokemeyer\u00a0C, Climent\u00a0MA, Daugaard\u00a0G, Gietema\u00a0JA, De Giorgi\u00a0U, Haugnes\u00a0HS, Huddart\u00a0RA, Le\u00e3o\u00a0R, Sohaib\u00a0A, Gillessen\u00a0S, Powles\u00a0T, EURACAN EGC (2022) Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33:362\u2013375","journal-title":"Ann Oncol"},{"key":"2675_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00120-022-01815-6","volume":"61","author":"KP Dieckmann","year":"2022","unstructured":"Dieckmann\u00a0KP, Ruf\u00a0CG, G\u00fcbitz\u00a0R, W\u00fclfing\u00a0C, Zengerling\u00a0F (2022) Nachsorge von Hodentumoren in der urologischen Praxis \u2013 historische Entwicklung und aktuelle Aspekte. Urologe\u00a0A 61:484\u2013494","journal-title":"Urologe A"},{"key":"2675_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf099","author":"A Mousa","year":"2025","unstructured":"Mousa\u00a0A, Amiri\u00a0A, Kaushal\u00a0S, Wilson\u00a0E, Jayalath\u00a0V, Nguyen\u00a0DD, Tan\u00a0I, Hamilton\u00a0RJ (2025) Secondary malignancies after treatment of testicular germ cell tumors: a\u00a0systematic review & meta-analysis. J\u00a0Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djaf099","journal-title":"J Natl Cancer Inst"},{"key":"2675_CR71","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1200\/JCO.22.01016","volume":"41","author":"S Lubberts","year":"2023","unstructured":"Lubberts\u00a0S, Groot\u00a0HJ, de Wit\u00a0R, Mulder\u00a0S, Witjes\u00a0JA, Kerst\u00a0JM, Groenewegen\u00a0G, Lefrandt\u00a0JD, van Leeuwen\u00a0FE, Nuver\u00a0J, Schaapveld\u00a0M, Gietema\u00a0JA (2023) Cardiovascular disease in testicular cancer survivors: identification of risk factors and impact on quality of life. J\u00a0Clin Oncol 41:3512\u20133522","journal-title":"J Clin Oncol"},{"key":"2675_CR72","doi-asserted-by":"publisher","first-page":"e70858","DOI":"10.1002\/cam4.70858","volume":"14","author":"D Puri","year":"2025","unstructured":"Puri\u00a0D, Riviere\u00a0P, Meagher\u00a0M, Morgan\u00a0K, Nelson\u00a0T, Yuen\u00a0K, Pandit\u00a0K, Yodkhunnatham\u00a0N, Taylor\u00a0J, Herchenhorn\u00a0D, Stewart\u00a0T, Javier-Desloges\u00a0J, Salmasi\u00a0A, McKay\u00a0RR, Kern\u00a0S (2025) Metabolic syndrome among testicular cancer survivors: long-term follow-up of the veterans affairs health system. Cancer Med 14:e70858","journal-title":"Cancer Med"},{"key":"2675_CR73","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.6004\/jnccn.2019.7369","volume":"17","author":"C Fung","year":"2019","unstructured":"Fung\u00a0C, Dinh\u00a0PC, Fossa\u00a0SD, Travis\u00a0LB (2019) Testicular cancer survivorship. J\u00a0Natl Compr Canc Netw 17:1557\u20131568","journal-title":"J Natl Compr Canc Netw"},{"key":"2675_CR74","first-page":"509","volume":"130","author":"HJ Illiger","year":"1988","unstructured":"Illiger\u00a0HJ (1988) Sinn und Unsinn der Tumornachsorge. Munch Med Wochenschr 130:509\u2013513","journal-title":"Munch. Med. Wochenschr."}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02675-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-025-02675-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02675-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T08:02:56Z","timestamp":1759392176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-025-02675-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1007\/s00120-025-02675-6","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"type":"print","value":"2731-7064"},{"type":"electronic","value":"2731-7072"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"assertion":[{"value":"12 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.-P.\u00a0Dieckmann verf\u00fcgt \u00fcber 5,7\u202f% Besitzanteile an der Firma miRdetect GmbH, Bremerhaven. M.\u00a0Angerer, F.\u00a0Bremmer und A.\u00a0Soave geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}